Abstract
Objective: To describe a case where continuous use of antithyroid medications was safely and effectively employed for the treatment of hyperthyroidism over a period of 14 years in a patient who refused radioactive ablative therapy and surgery. Case Report: The patient is a 71-year-old woman who presented with complaints of tachycardia and tremors along with a diffusely enlarged goiter without appreciable nodules. At the time of evaluation, she was clinically and biochemically hyperthyroid. An I123 thyroid uptake and scan revealed a toxic multinodular goiter. She was started on propylthiouracil therapy, which was discontinued due to generalized pruritus. After approximately 4 months of refusing alternative antithyroid therapy, she was started on methimazole. In the subsequent 14 years of management, she relapsed 3 times off antithyroid drugs. However, she never developed any major side effects with the maintenance of methimazole dose of 5 mg daily. Conclusions: The goal of treatment for hyperthyroidism is to render the patient euthyroid safely. However, when treated with radioactive ablative therapy or surgery, the patient is at high risk of being on lifelong thyroxine therapy. Therefore, it appears reasonable that well-informed patients who would prefer lifelong antithyroid therapy, as opposed to lifelong thyroxine therapy, should be given that option.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.